Pharmsville Co., Ltd. (KOSDAQ:318010)

Pharmsville Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,561	17,802	5,470	18,210	14,031	9,557
Short-Term Investments	-	-	3,000	3,000	22,204	1,221
Trading Asset Securities	37,103	19,874	31,077	21,625	5,499	25,519
Cash & Short-Term Investments	39,664	37,676	39,546	42,835	41,735	36,297
Cash Growth	1.07%	-4.73%	-7.68%	2.63%	14.98%	-7.27%
Accounts Receivable	947.03	1,047	1,176	1,942	2,430	1,934
Other Receivables	53.68	84.84	99.53	162.14	55.48	93.07
Receivables	1,001	1,131	1,275	2,104	2,485	2,027
Inventory	1,555	2,067	2,631	2,588	4,287	5,016
Prepaid Expenses	118.09	112.63	135.4	122.16	25.5	355.14
Other Current Assets	40.77	246.65	38.69	150.03	148.65	232.21
Total Current Assets	42,378	41,234	43,627	47,798	48,682	43,927
Property, Plant & Equipment	13,744	14,329	14,847	15,219	15,663	15,867
Long-Term Investments	6,269	4,404	5,389	5,372	3,374	2,882
Other Intangible Assets	471.76	450.82	391.88	447.39	443.92	446.09
Long-Term Accounts Receivable	-	-	-	-0	-0	-0
Long-Term Deferred Tax Assets	1,052	1,052	1,163	1,051	1,109	764.95
Other Long-Term Assets	4,590	4,670	4,861	4,948	5,035	5,150
Total Assets	68,507	67,140	71,279	74,835	74,307	69,037
Accounts Payable	778.35	884.68	1,444	1,337	2,175	2,491
Accrued Expenses	33.4	333.58	595.79	1,221	1,035	599.46
Current Portion of Long-Term Debt	-	-	2,182	3,636	2,667	416.62
Current Portion of Leases	4.63	7.12	5.35	6.48	9.41	5.49
Current Income Taxes Payable	515.55	-	160.25	425.46	1,052	62.82
Other Current Liabilities	859.31	939.83	1,062	306.61	302.45	246.01
Total Current Liabilities	2,191	2,165	5,449	6,933	7,240	3,822
Long-Term Debt	-	-	-	3,636	5,333	8,000
Long-Term Leases	12.99	16.48	2.65	7.12	13.6	-
Pension & Post-Retirement Benefits	45.09	-	1,481	1,255	2,081	1,117
Other Long-Term Liabilities	334	334	329.5	337	335	336.37
Total Liabilities	2,583	2,516	7,263	12,168	15,003	13,275
Common Stock	3,965	3,965	3,965	3,965	3,965	3,965
Additional Paid-In Capital	22,365	22,365	22,365	22,400	22,365	22,365
Retained Earnings	41,482	40,190	40,222	37,776	34,415	30,870
Treasury Stock	-1,998	-1,998	-1,815	-998.09	-998.09	-998.09
Comprehensive Income & Other	-0	-0	-822.85	-580.97	-546	-546
Total Common Equity	65,813	64,522	63,914	62,562	59,200	55,655
Minority Interest	109.83	102.36	102.26	104.85	103.91	107.07
Shareholders' Equity	65,923	64,624	64,016	62,667	59,304	55,762
Total Liabilities & Equity	68,507	67,140	71,279	74,835	74,307	69,037
Total Debt	17.62	23.6	2,190	7,286	8,023	8,422
Net Cash (Debt)	39,646	37,652	37,356	35,548	33,712	27,875
Net Cash Growth	2.51%	0.79%	5.09%	5.45%	20.94%	-17.44%
Net Cash Per Share	5133.55	4872.03	4770.04	4530.52	4296.44	3542.09
Filing Date Shares Outstanding	7.71	7.73	7.75	7.85	7.85	7.85
Total Common Shares Outstanding	7.71	7.73	7.75	7.85	7.85	7.85
Working Capital	40,186	39,069	38,177	40,866	41,442	40,106
Book Value Per Share	8532.47	8348.98	8247.04	7973.30	7544.87	7093.03
Tangible Book Value	65,342	64,071	63,522	62,115	58,756	55,209
Tangible Book Value Per Share	8471.31	8290.64	8196.48	7916.28	7488.30	7036.18
Land	3,426	3,594	3,594	3,479	3,380	3,380
Buildings	11,805	11,805	11,805	11,805	11,805	11,805
Machinery	1,444	1,441	1,418	1,339	1,476	1,206

Source: S&P Global Market Intelligence. Standard template. Financial Sources.